Company
aprilbio.com
AprilBio develops innovative new drugs based on its proprietary antibody-fragment technology
Also known as APRILBIO
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- 춘천시, 강원특별자치도, South Korea
Claim, correct or request removal
Record updated 28 September 2026
About
Based on our proprietary albumin binder fusion technology SAFA (anti-Serum Albumin Fab Associated), we are developing new drugs with improved efficacy and half-life and minimized side effects.
Products
- Other
- APB-A1
- Other
- APB-R3
Loading relationship preview